A carregar...

Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a.

A prospective randomised, double blind, controlled trial was conducted in 52 infants to determine whether recombinant interferon alfa-2a (INF-alpha-2a) would reduce the morbidity of acute bronchiolitis and the respiratory syncytial virus shedding time. All infants had a positive direct antigen immun...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sung, R Y, Yin, J, Oppenheimer, S J, Tam, J S, Lau, J
Formato: Artigo
Idioma:Inglês
Publicado em: 1993
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1029552/
https://ncbi.nlm.nih.gov/pubmed/8259875
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!